Bright Futures Health · Health news

Children’s health news, read by a paediatrician

Guidance for parents changes more often than most families have time to follow. Each week we read what UKHSA, the NHS, the RCPCH and the journals have published, keep the handful of things that actually change what you should do for your child, and say plainly what we think it means. Every item links to the original source.

Four children dressed up in white coats with toy stethoscopes

Last reviewed 19 October 2026 by Dr Martin Gray, Consultant Paediatrician

15 items

UKHSAInfections15 October 2026

The RSV season has started — what it means for babies and toddlers

UKHSA’s national flu and COVID-19 surveillance report, published on 15 October 2026 and covering week 41 (5 to 11 October), reports that hospital admissions for RSV in children under 5 in England increased on the previous week, and that RSV positivity in 0 to 4 year olds also increased. Flu activity overall remained at baseline levels, though influenza B positivity rose in 5 to 11 year olds. UKHSA also published provisional flu vaccine uptake for children aged 2 and 3 years, noting the figures should be interpreted with caution because pharmacy data is incomplete. These reports are republished weekly, so the current position is always in the most recent one.

Our take

The signal worth having is that the RSV season has started, rather than any single week’s number — and RSV is the winter infection that puts the most babies in hospital. If you are pregnant, the RSV vaccine from 28 weeks is the single thing that protects a newborn through their first months, and if your 28-week appointment has passed without it being offered, ask your maternity team rather than waiting. For a baby already here, the signs that need same-day assessment are fast or laboured breathing, pulling in under the ribs, long pauses in breathing, or taking less than about half their usual feeds; a cough and a snotty nose alone usually just need patience. And only a minority of 2 and 3 year olds have had their flu vaccine so far — that appointment is at your GP surgery, and nursery will not do it for you.

Read the UKHSA surveillance report
King’s College LondonWellbeing13 October 2026

Most south London teenagers with a mental health disorder never receive an NHS diagnosis

17-year-olds given any diagnosis by NHS mental health services, south London

4.4%

in 2024, up from 2.6% in 2009 — while across the study period fewer than 1 in 15 of those estimated to have a disorder received a diagnosis from NHS mental health services.

Among young people who had a disorder and had already seen a health professional for help, fewer than 1 in 4 received an NHS mental health diagnosis.

Figures: E-Risk Longitudinal Twin Study, King’s College London, published in The Lancet Regional Health – Europe.

A King’s College London study published in The Lancet Regional Health – Europe compared the diagnoses recorded by NHS mental health services with the disorders identified by research interviews in over 2,000 young people in the E-Risk Longitudinal Twin Study. The proportion of 17-year-olds in south London receiving any diagnosis from NHS mental health services rose from 2.6% in 2009 to 4.4% in 2024, but across the study period fewer than 1 in 15 of those estimated to have depression, generalised anxiety disorder, PTSD, conduct disorder or ADHD received a diagnosis from NHS services. The authors point to high access thresholds, limited capacity to assess, and young people’s own uncertainty about where to seek help.

Our take

This is one cohort in one part of our city rather than a national audit, so treat the exact proportions carefully — but the direction will be familiar to any parent who has tried to get a teenager assessed, and the figures are about London. The practical lesson is not to read the absence of a diagnosis as the absence of a problem: if your child is struggling, keep a short written record of what you are seeing and for how long, and ask explicitly for an assessment rather than general support, because a named condition is what most NHS treatments are attached to. It also sits alongside the Fonagy review published on 9 October, which promised help without waiting for a diagnosis — both things are true at once, and the right move is usually to take the support on offer now while staying on the assessment list.

Read the King’s College London summary
UKHSAInfections6 October 2026

Half of England’s measles cases this year have been in London

London’s share of England’s measles cases, 2026

50%

of England’s 1,003 laboratory-confirmed measles cases between 1 January and 14 September 2026 were in London — 505 of the 1,003.

61% of cases in England (610 of 1,003) were in children aged 10 years and under. UKHSA describes the data as provisional and subject to change.

Figures: UK Health Security Agency, © Crown copyright, licensed under the Open Government Licence v3.0.

UKHSA has updated its 2026 measles figures for England. Between 1 January and 14 September 2026 there were 1,003 laboratory-confirmed cases, 505 of them — 50% — in London, and 610 of the 1,003 (61%) were in children aged 10 years and under. The data is provisional and subject to change, and the next update is due on 15 October 2026.

Our take

There is nothing new to do here, but there is something worth checking — London accounts for half of England’s measles cases this year, so a national figure does not describe our city. Six in ten cases are in children aged 10 and under, and in London the largest group is 1 to 4 year olds, which is exactly the age at which an MMR course is still being completed; the second dose, due at 3 years 4 months, is the one most often missed. If you are not certain your child has had both doses, bring the red book to your next appointment or ask your GP — there is no upper age limit for catching up, and a dose missed at three can still be given at eight.

Read the UKHSA figures
MHRASafety5 October 2026

Two batches of Movicol Plain recalled from pharmacies — if you already have it at home, keep using it

The MHRA has issued a Class 3 Medicines Recall for MOVICOL Plain 13.7g powder for oral solution, made by Norgine Limited, because some units contain the incorrect amounts of active ingredients. Two batches are affected, both in packs of 30: batch 487069, expiry 28/02/2029, and batch 474919, expiry 31/08/2028. Pharmacies and wholesalers are told to stop supplying the batches immediately and quarantine remaining stock. The alert states that no further action is required by patients, and that patients who already have one of these batches may continue to take the medicine.

Our take

If your child takes Movicol Plain for constipation, there is nothing you need to do — the recall is being handled at pharmacy and wholesaler level, and the MHRA is explicit that anyone who already has one of these batches at home can carry on using it as prescribed. Movicol Plain 13.7g is the strength licensed from 12 years upwards, so this is a teenager’s box rather than a younger child’s; under-12s are prescribed Movicol Paediatric Plain, which is not affected. The thing we would most want to avoid is treatment being stopped on the strength of the word “recall” — in chronic constipation a few missed days can undo weeks of progress, so if you are uneasy about a box you have at home, ring us or your pharmacist before stopping anything.

Read the MHRA recall
UKHSAVaccination1 October 2026

Only a quarter of eligible young people have had the one-off MenB vaccine, and London is lowest

UKHSA has published the first uptake figures for the 2026 one-off MenB programme, covering data up to 20 September 2026. Coverage of the first dose was 26.6% — 212,549 vaccinated out of 799,840 eligible individuals — ranging from the lowest in London, 21%, to the highest in the South East, 31.6%, and from 11.8% in the most deprived to 45% in the least deprived areas. Two doses are needed for protection, and they have to be given at least 28 days apart.

Our take

If you have a teenager in this group — school Year 13 in 2025/26, or starting university or a residential college for the first time this autumn — there is a good chance they have not had it, because three quarters of eligible young people have not, and London is the worst region in the country. Two doses are needed and they have to be at least 28 days apart, so booking the first one now rather than at Christmas is what makes the second dose possible inside the programme. Meningococcal disease moves in hours rather than days in this age group, and the vaccine is the only part of it you can do anything about in advance.

Read the UKHSA announcement
MHRASafety1 October 2026

Missing safety wording in the leaflet for one brand of liquid levetiracetam — keep giving it as prescribed

The MHRA has issued a Class 4 Medicines Defect Notification for Levetiracetam Neuraxpharm granules for oral solution in sachets, covering the 250mg, 500mg, 750mg, 1000mg and 1500mg strengths. The patient information leaflet omits wording that should appear, including use in infants from one month of age, obsessive-compulsive disorder as a rare adverse reaction, and multiorgan hypersensitivity (DRESS). The affected batches are not being recalled: prescribers are told to continue prescribing and dispensing in accordance with the approved product information, and patients to continue taking medicines from these batches as prescribed.

Our take

If your child takes levetiracetam as a liquid or sachet for epilepsy, nothing about the medicine itself has changed and you should keep giving it exactly as prescribed — the problem is wording left out of the printed leaflet, not the drug. What that leaflet should have told you is worth knowing anyway: seek advice urgently if your child develops a high fever with muscle stiffness and confusion, or a fever with a rash, facial swelling or swollen glands, and speak to us or your epilepsy team about any new obsessive thoughts or behaviours, or seizures that change or worsen. This brand is often the one used for children who cannot swallow tablets, so it is worth checking the box if you are not sure which you have.

Read the MHRA notification
BMJ GroupWellbeing22 September 2026

Ketamine bladder damage — a specialist UK clinic is seeing children as young as 13

A study in Archives of Disease in Childhood describes the first 60 under-16s referred to a dedicated UK clinic for bladder problems caused by non-prescribed ketamine. Their average age was 14 and the youngest was 13; 43 of the 60 were girls. Most had been using ketamine for one to two years before they were referred. The authors call for services for under-16s to be co-designed with young people and delivered in a trauma-informed, accessible way.

Our take

One clinic’s caseload does not change anything about your own child’s care, and this is not a common problem — but the ages are worth knowing, because this is a Year 9 and Year 10 picture rather than a university one. What matters clinically is that ketamine damages the bladder, and the early signs look like a urine infection: passing urine very often, pain on passing it, or blood in it. If a teenager has those symptoms and no infection is found, ask about ketamine openly rather than waiting — the bladder damage is far more treatable early, and we would far rather have that conversation than miss it.

Read the research summary
UKHSAInfections21 September 2026

Scarlet fever — the signs to look for, and when your child can go back to school

UKHSA has published a guide to scarlet fever. Around 90% of cases occur in children under 10, with the highest rates in children aged 2 to 8. Symptoms often start with a sore throat, fever, headache, nausea and vomiting, followed after 12 to 48 hours by a rash that feels rough, like sandpaper. It is treated with a 10-day course of antibiotics, and children should stay away from nursery or school until at least 24 hours after starting them; people can pass the infection on before they show symptoms.

Our take

Nothing in the guidance has changed — this is UKHSA’s start-of-term reminder, and it is worth reading because scarlet fever usually picks up as schools return. The sandpaper feel of the rash is the most useful clue at home; if you notice it with a sore throat and fever, call your GP, NHS 111 or us the same day. Finish the whole 10-day antibiotic course even once your child feels well, and seek advice again if they worsen or develop new symptoms in the weeks after recovery.

Read the UKHSA guide
Earlier items
UKHSAVaccination11 September 2026

RSV vaccination in pregnancy — who is eligible, and when it is given

UKHSA has set out who is eligible for the RSV vaccine. Pregnant women are offered it from week 28 of every pregnancy, to protect each new baby. Adults aged 75 and over, all residents of care homes for older adults, and adults aged 65 to 74 with long-term lung conditions or weakened immune systems are also eligible. UKHSA reports that vaccination in pregnancy reduces the risk of severe RSV lung infection by 80% in a baby’s first months of life, and that England recorded 50% fewer infants under 6 months admitted to intensive care with RSV in 2025–26.

Our take

If you are expecting a baby this winter, this is the single most useful thing you can do for them — the baby cannot be vaccinated, so the protection has to come through you before birth. It is offered from 28 weeks and in every pregnancy, not once. If you have passed your 28-week appointment and it was not offered, contact your maternity service rather than waiting to be called.

Read the RSV guide
NHS EnglandInfections10 September 2026

Pharmacies to treat five more conditions, including hay fever in children

NHS England is adding five prescribing pathways to Pharmacy First: low frequency episodic migraine in adults, seasonal allergic rhinitis in children, acute otitis externa in adults, mild to moderate acne in young people and adults, and mild skin and soft tissue infections and scabies. NHS England estimates 2 to 3 million consultations for the 5 conditions could take place each year. The service starts from autumn 2026, in the initial small number of community pharmacies that become a prescribing pharmacy in 2026/27.

Our take

For children the pathway that matters is seasonal allergic rhinitis — hay fever treatment without waiting for a GP appointment. Read the ear infection line carefully: it covers acute otitis externa in adults, so a child with earache is not included, and earache in a child is usually otitis media and still needs assessing. Only a small number of pharmacies are prescribing in the first year, so ring ahead rather than turning up.

Read the NHS England announcement
UKHSAVaccination9 September 2026

Autumn COVID-19 vaccine — only immunosuppressed children are eligible

UKHSA has confirmed that the autumn 2026 COVID-19 vaccination is offered to adults aged 75 years and over, residents in care homes for older adults, and individuals who are immunosuppressed aged 6 months and over, on the same basis across all four UK nations. Booking is open and appointments run from 1 October. The vaccine should usually be offered no earlier than around 6 months after the last dose.

Our take

For almost every child this changes nothing — healthy children are not eligible this autumn and do not need a COVID-19 vaccine. The exception is a child aged 6 months or over who is immunosuppressed, whether from a condition or from treatment, and those families should book for 1 October while keeping the roughly 6-month gap since the last dose. If you are not sure whether your child’s diagnosis or medication puts them in that group, ask us rather than guessing from the list.

Read the eligibility guidance
UKHSAVaccination7 September 2026

Only half of primary school children had a flu vaccine last year

Primary school flu uptake, England

55.5%

of eligible primary school children vaccinated in 2025–26 — about 2.5 million of 4.5 million.

2020–2162.5%
2024–2554.5%
2025–2655.5%

Selected years, not consecutive. Chart: Bright Futures Health. Data: UK Health Security Agency, © Crown copyright, licensed under the Open Government Licence v3.0.

Uptake in primary schools reached 55.5% in 2025–26 — up marginally on the year before but still below the 60%-plus seen before the pandemic. School sessions for this autumn began in the week of the announcement, and UKHSA is asking parents to return consent forms promptly.

Our take

The commonest reason a child misses the school flu vaccine is not refusal — it is a consent form still in a school bag. If you want your child vaccinated, sign and return it now rather than at the reminder. Children who miss the school session can still be caught up, and from December pharmacies are being asked to help with exactly that.

Read the UKHSA announcement
UKHSAVaccination27 August 2026

Who can have the autumn 2026 flu vaccine

The programme opened on 1 September. Eligible children are those aged 2 or 3 on 31 August 2026, every child from Reception to Year 11, and any child from 6 months to under 18 in a clinical risk group. Most are offered the nasal spray rather than an injection. From 1 October some community pharmacies can vaccinate at-risk children aged 2–17.

Our take

Two questions come up every autumn. The nasal spray contains a weakened virus: it cannot give your child flu, and a vaccinated child is not a risk to an immunosuppressed sibling or grandparent. And a two- or three-year-old is vaccinated at the GP surgery, not at nursery — that appointment has to be booked by you.

Read the eligibility guide
UKHSAInfections5 March 2026

Recognising measles, and why two doses matter

UKHSA has re-issued its guidance on spotting measles in children: cold-like symptoms and fever first, sore red eyes, small white spots inside the cheeks, then a blotchy rash starting at the face and spreading down. Two doses of an MMR-containing vaccine give around 99% protection.

Our take

Measles is far more serious than the rash suggests, and it spreads before the rash appears. If you think your child may have it, phone ahead rather than sitting in a waiting room — we can see them without exposing other children, and that call matters more than the appointment itself.

Read the measles guidance
UKHSAVaccinationJanuary 2026

The childhood schedule changed in January — MMRV and a new 18-month visit

MMR has been replaced by MMRV, which adds chickenpox. Children born on or after 1 September 2022 are offered it routinely; those born between 1 January 2020 and 31 August 2022 are offered a single catch-up dose. Hib/MenC has gone from the one-year appointment, with Hib protection now carried by a fourth 6-in-1 dose at a new 18-month visit for children born on or after 1 July 2024. The second MenB dose moved earlier, to 12 weeks; the first pneumococcal dose moved later, to 16 weeks.

Our take

This is the biggest change to the schedule in years and the catch-up cohorts are easy to miss, particularly for families who moved to the UK mid-schedule or whose child was born abroad. If you are not certain your child is up to date, bring the red book to your next appointment and we will map it against the current schedule properly.

Read what changed

Keep up without the searching

A short round-up, straight to your inbox

We send the items that matter to London families, with the clinical reasoning left in. No more than monthly.

About this page

These are summaries of guidance and research published elsewhere, with our clinical interpretation added. They are general information, not advice about your own child, and guidance changes — always check the linked source for the current position. If you are worried about your child now, contact us, speak to your GP, or call NHS 111. If a child is seriously unwell, call 999.

Curated and reviewed by Dr Martin Gray, Consultant Paediatrician, Bright Futures Health.

Sources and credits

Headlines and figures are summarised from the linked publications and remain the copyright of their publishers. Charts on this page are drawn by Bright Futures Health from data published by the UK Health Security Agency and other public bodies, © Crown copyright, licensed under the Open Government Licence v3.0. All illustrations are original artwork by Bright Futures Health. No photographs, logos or emblems belonging to UKHSA, the NHS, the RCPCH or any publisher are reproduced on this page.